Ranch Capital Advisors Inc. Amgen Inc Transaction History

Ranch Capital Advisors Inc.

$210 Million
Q3 2024

A detailed history of Ranch Capital Advisors Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 8,417 shares of AMGN stock, worth $2.48 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

8,417

Previous 7,931 6.13%

Holding current value

$2.48 Million

Previous $2.48 Million 9.44%

% of portfolio

1.29%

Previous 1.3%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $150,358 - $163,966	486 Added 6.13%	8,417 $2.71 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $13,663 - $16,604	52 Added 0.66%	7,931 $2.48 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $51,354 - $61,990	191 Added 2.48%	7,879 $2.24 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $130,662 - $147,403	511 Added 7.12%	7,688 $2.21 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $8,090 - $10,044	-37 Reduced 0.51%	7,177 $1.93 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $2,785 - $3,293	-13 Reduced 0.18%	7,214 $1.6 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $30,481 - $37,152	135 Added 1.9%	7,227 $1.75 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $18,551 - $23,571	-81 Reduced 1.13%	7,092 $1.86 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $16,385 - $18,479	73 Added 1.03%	7,173 $1.62 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $38,528 - $42,875	167 Added 2.41%	7,100 $1.73 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $47,800 - $52,880	218 Added 3.25%	6,933 $1.68 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $23,865 - $27,312	120 Added 1.82%	6,715 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $98,281 - $115,148	463 Added 7.55%	6,595 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $111,651 - $123,868	478 Added 8.45%	6,132 $1.49 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $61,469 - $71,632	277 Added 5.15%	5,654 $1.41 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $87,850 - $104,614	-406 Reduced 7.02%	5,377 $1.24 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1,642 - $1,826	-7 Reduced 0.12%	5,783 $1.47 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $260,317 - $319,445	1,316 Added 29.41%	5,790 $1.38 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $102,054 - $135,352	560 Added 14.31%	4,474 $907,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $56,384 - $72,473	298 Added 8.24%	3,914 $943,000
Q3 2019 Nov 18, 2019	BUY	$174.11 - $208.62 $629,581 - $754,369	3,616 New	3,616 $700,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.

Account

Ranch Capital Advisors Inc. Amgen Inc Transaction History